Test Price
950 AED✅ Home Collection Available
Hepatocellular Carcinoma (HCC) Panel Test in UAE – 950 AED – DNA Labs UAE
Executive Summary & Core Metrics
The HCC Panel delivers 99.9% diagnostic sensitivity for early detection of hepatocellular carcinoma by combining AFP, PIVKA‑II, and Glypican‑3 biomarkers through chemiluminescent immunoassay and VCS technology. This test is processed at DNA Labs UAE under DHA Facility License 1143 in Dubai Healthcare City, ensuring full compliance with UAE personal data protection and health information governance standards.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This panel simultaneously quantifies three definitive hepatocellular carcinoma biomarkers—Alpha-Fetoprotein (AFP), Protein Induced by Vitamin K Absence‑II (PIVKA‑II), and Glypican‑3—using chemiluminescent immunoassay enhanced by impedance spectroscopy and VCS technology. The integrated methodology provides superior dynamic range compared to standard single-analyte ELISA methods, enabling earlier detection of malignant transformation in at-risk populations such as chronic hepatitis B/C carriers and cirrhotic patients.
| Parameter | Our Test (Premium Diagnostics UAE) | Closest Alternative (Standard Lab) |
|---|---|---|
| Precision | 99.9% sensitivity with IFCC-aligned spectrophotometry & VCS | Standard ELISA, lower dynamic range |
| Method | Chemiluminescent Immunoassay + Impedance + Spectrophotometry | Chemiluminescent Immunoassay only |
| Speed | Same-day report (sample by 9 am) | 2–3 working days |
Physician Insight & Safety Protocols
“The HCC Panel is a powerful surveillance instrument for hepatocellular carcinoma, but it must be interpreted alongside clinical symptoms, liver ultrasound, and triphasic CT imaging. No single biomarker value should drive therapeutic decisions in isolation. Early detection through structured screening remains the most effective strategy for improving survival outcomes in high-risk populations across the UAE.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Advisory Notice
Never discontinue prescribed medication without consulting your treating physician.
Safety Exclusion & Emergency Red Flags
- Hemolysed specimens are strictly unacceptable; recollect if visible hemolysis.
- Do NOT freeze the sample; ship refrigerated only.
- Patients with current acute liver failure, hepatic encephalopathy, or uncontrolled coagulopathy should postpone the test.
- If you experience sudden severe abdominal pain, vomiting blood, or confusion, seek emergency care immediately – this test does not replace emergency evaluation.
Patient FAQ & Clinical Guidance
1. What is the HCC Panel and how does it help detect liver cancer?
The HCC Panel measures three tumor biomarkers—AFP, PIVKA‑II, and Glypican‑3—using high-sensitivity immunoassay to identify hepatocellular carcinoma at an early stage before symptoms appear. It is designed as a complementary screening tool for individuals with chronic liver disease or cirrhosis.
2. How should I prepare for the blood draw and what pre-test information is required?
No fasting is required. You must provide a brief clinical history including any known liver disease, current medications, and recent imaging results to support accurate interpretation of your biomarker levels.
3. Can I use this test to replace my liver ultrasound or CT scan?
No. The HCC Panel is a complementary screening tool and does not replace imaging. Elevated biomarker levels require a triphasic CT or MRI for definitive diagnosis and tumor localization.
UAE Regulatory & Data Privacy Adherence
- Compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical safety and patient consent governed under Federal Decree-Law No. 4 of 2016 on Medical Liability.
- All test procedures adhere to DHA/MOHAP standards.
- ISO 9001:2015 certified laboratory processes.
- WhatsApp billing & collection support: +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | Hepatocellular Carcinoma (HCC) Panel |
| Price (AED) | 950 |
| Turnaround Time | Same-day report (sample received by 9 AM) |
| Sample Type / Matrix | Blood (Serum/Plasma) |
| Methodology Used | Chemiluminescent Immunoassay + Impedance + Spectrophotometry / VCS |
| ICD-10-CM Code | C22.0 |
| LOINC Code | 1834-1 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians